Created at	Source	Raw Value	Validated value
March 26, 2021, 2:21 p.m.	oms	Efficacy of recombinant COVID-19 vaccine (Sf9 cells) in preventing virologically confirmed (PCR positive) symptomatic COVID-19;Safety of recombinant COVID-19 vaccine (Sf9 cells) in terms of SAE; MAAE and AESI in all participants from Day 0 through 6 months after completion of 3 doses vaccination	Efficacy of recombinant COVID-19 vaccine (Sf9 cells) in preventing virologically confirmed (PCR positive) symptomatic COVID-19;Safety of recombinant COVID-19 vaccine (Sf9 cells) in terms of SAE; MAAE and AESI in all participants from Day 0 through 6 months after completion of 3 doses vaccination